Vulvular Cancer
Vulvular Cancer
Vulvular Cancer
uncommon, representing about 4% malignancies of female genital tract. squamous cell ca account for about 90% of the cases (much less common: melanomas, adenoca, basal cell ca, sarcomas)
"
in situ vulvar ca - doubled between mid-1970s and mid-1980s (rate of invasive squamous cell ca remained sable)
VIN 1 - immature cells, cellular disorganisation, mitotic activity in the lower one- third of the epithelium, VIN 2 - immature cells with scanty cytoplasm and severe chromatinic alterations occupy most of the epithelium (changes of HPV info : perinuclear halos with displacement of the muclei by the intracytoplasmic viral protein, thickened cell borders, binucleation, multinucleation)
VIN 3 - unifocal or multifocal: small hyperpigmented lesions on the labia major,
(clinically: multiple small, pigmented papules less than 5 mm - 40% cases (bowenoid papulosis = dysplasia)
must be distinguished from superficial spreading melanoma, Clinical: affects postmenopausal Caucasian woll)~n, symptoms - pruritus and ,vulvar soreness. Eczematoid lesion, begins on the hair-bearing portion of the vulva. VIN treatment:
history of vulvar condylomata or granulomatous venera disease, v. ca ocassionally arise from areas of ca-in-situ, occur more frequently in women who have been treated for invasive squamous carcinomas of the cervix or vagina, more than half of the patients are between 60 and 79, fewer than 15% are under age of 40. obese, hypertensive, diabetic or nulliparous patients - more common
Etiology: HPV DNA has been reported in 20-60% of patients with invasive vulvar cancer (HPVpositive group: younger mean age, more tabacco use, presence of VIN associated with the invasive cpmponent). Approximately 90-92% of all invasive vulvar cancers are of the squamous celr type.
Physical examination: the lesion is usually raised and may be fleshy, ulcerated, leukoplakic or
warty (20%). Most squamous ca occur on the labia majora (labia minora, clitoris, perineum also may be primary sites). About 5% cases - multifocal, 10% too extensive to determine a site of origin.
Diagnosis: requires a wedge biopsy specimen, usually taken under local anesthesia. About 1 cm
lesion - excisional biopsy is preferable.